Chimera Investment Corp. Operating Cash Flow increased by 259.3% to $243.32M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 398.6%, from $48.80M to $243.32M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -16.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $137.29M | $150.60M | $109.09M | $135.92M | $122.74M | $40.63M | $26.44M | $30.44M | $106.82M | $44.68M | $31.33M | $57.27M | $69.03M | $41.42M | $37.95M | $48.80M | -$7.43M | -$137.48M | -$152.77M | $243.32M |
| QoQ Change | — | +9.7% | -27.6% | +24.6% | -9.7% | -66.9% | -34.9% | +15.2% | +250.9% | -58.2% | -29.9% | +82.8% | +20.5% | -40.0% | -8.4% | +28.6% | -115.2% | <-999% | -11.1% | +259.3% |
| YoY Change | — | — | — | — | -10.6% | -73.0% | -75.8% | -77.6% | -13.0% | +10.0% | +18.5% | +88.1% | -35.4% | -7.3% | +21.1% | -14.8% | -110.8% | -431.9% | -502.6% | +398.6% |